The authors reported a new strategy of blocking the CD7 antigen on the T cell surface with a recombinant anti-CD7 antibody to obtain a sufficient amount of CD7-targeting CAR-T cells for T cell acute lymphoblastic leukemia treatment.
[Molecular Therapy-Oncolytics]
6445212
BBBBBBBB
items
1
apa
0
default
asc
1
172087
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
